Since our data showed that the differences in the expression of PD-L1 and PD-1 in tumor cells and TIICs were clustered in the periphery of SGC patients’ tumors, we next evaluated whether this clustering also correlated with disease severity (tumor grade, primary tumor stage, and the presence of LN metastases). Here, PDCD1 is linked to neoplasm.